Skip to the page

Data / Drug companies / Medichem S.A.

Medichem S.A.: 43 products in the FDA NDC directory, labeler code 53296

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Medichem S.A. (labeler code 53296) lists 43 products in the FDA National Drug Code Directory. By type: 42 bulk ingredients, 1 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on May 29, 2026.

The request: Watch Medichem S.A. (FDA labeler code 53296): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
53296
Products in commercial distribution
43
Packages
45
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
1
Earliest marketing start
December 15, 2009
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients4297.7%
Drugs for further processing12.3%

Products by type

TypeProductsShare
Bulk ingredients4297.7%
Drugs for further processing12.3%

Dosage forms

Dosage formProductsShare
Powder4297.7%
Solution12.3%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Apixaban53296-0113PowderBulk ingredientsMay 29, 2026
Ivacaftor53296-0132PowderBulk ingredientsAugust 2, 2024
Relugolix53296-0131PowderBulk ingredientsAugust 2, 2024
Voclosporin53296-0130PowderBulk ingredientsAugust 2, 2024
Cinacalcet hydrochloride53296-0082PowderBulk ingredientsFebruary 15, 2023
Lofexidine hydrochloride53296-0128PowderBulk ingredientsNovember 18, 2020
Revefenacin53296-0127PowderBulk ingredientsNovember 18, 2020
Pazopanib hydrochloride53296-0125PowderBulk ingredientsNovember 18, 2020
Octenidine dihydrochloride53296-0122PowderBulk ingredientsJanuary 2, 2019
Edaravone53296-0120PowderBulk ingredientsJanuary 2, 2019
Sugammadex sodium53296-0119PowderBulk ingredientsNovember 27, 2017
Brimonidine tartrate53296-0050PowderBulk ingredientsSeptember 1, 2014
Pimecrolimus53296-0115PowderBulk ingredientsJuly 1, 2014
Micafungin sodium53296-0114PowderBulk ingredientsJuly 1, 2014
Rivaroxaban53296-0109PowderBulk ingredientsDecember 20, 2011
Asenapine maleate53296-0104PowderBulk ingredientsApril 19, 2011
Loxapine53296-0095PowderBulk ingredientsJune 2, 2010
Sunitinib malate53296-0091PowderBulk ingredientsJune 2, 2010
Chlorhexidine53296-0010PowderBulk ingredientsJune 2, 2010
Desvenlafaxine succinate53296-0087PowderBulk ingredientsJune 1, 2010
Voriconazole53296-0081PowderBulk ingredientsMay 27, 2010
Olopatadine hcl53296-0078PowderBulk ingredientsMay 27, 2010
Tamsulosin hydrochloride53296-0073PowderBulk ingredientsMay 27, 2010
Adapalene53296-0068PowderBulk ingredientsMay 21, 2010
Quetiapine fumarate53296-0061PowderBulk ingredientsMay 19, 2010

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.